Patents by Inventor In-June Cha

In-June Cha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF
    Publication number: 20130095478
    Abstract: The present invention relates to htSNPs for determining a genotype of cytochrome P450 1A2 (CYP1A2), 2A6 (CYP2A6) and 2D6 (CYP2D6), PXR and UDP-glucuronosyltransferase 1a (UGT1A) genes and a gene chip using the same, and more particularly, to a selection method of htSNPs for determining a haplotype of human CYP1A2, CYP2A6, CYP2D6, PXR and UGT1A genes, a method of determining a genotype of the genes by using the htSNPs and a gene chip therefor.
    Type: Application
    Filed: July 16, 2012
    Publication date: April 18, 2013
    Applicant: Inje University Industry Academic Cooperation Foundation
    Inventors: Jae-Gook SHIN, Yin-Jin Jang, Sang-seop Lee, Hye-eun Jeong, In-june Cha, Woo-young Kim, Sung-su Yea, Eun-young Kim, Eun-young Cha, Ji-hong Shon, Eun-jeong Choi, Kang-mi Kim, Hyun-ju Jung
  • HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF
    Publication number: 20130096010
    Abstract: The present invention relates to htSNPs for determining a genotype of cytochrome P450 1A2 (CYP1A2), 2A6 (CYP2A6) and 2D6 (CYP2D6), PXR and UDP-glucuronosyltransferase 1a (UGT1A) genes and a gene chip using the same, and more particularly, to a selection method of htSNPs for determining a haplotype of human CYP1A2, CYP2A6, CYP2D6, PXR and UGT1A genes, a method of determining a genotype of the genes by using the htSNPs and a gene chip therefor.
    Type: Application
    Filed: July 16, 2012
    Publication date: April 18, 2013
    Applicant: INJE UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Jae-Gook SHIN, Yin-jin JANG, Sang-seop LEE, Hye-eun JEONG, In-june CHA, Woo-young KIM, Sung-su YEA, Eun-young KIM, Eun-young CHA, Ji-hong SHON, Eun-jeong CHOI, Kang-mi KIM, Hyun-ju JUNG
  • HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF
    Publication number: 20100159454
    Abstract: The present invention relates to htSNPs for determining a genotype of cytochrome P450 1A2 (CYP1A2), 2A6 (CYP2A6) and 2D6 (CYP2D6), PXR and UDP-glucuronosyltransferase Ia (UGT1A) genes and a gene chip using the same, and more particularly, to a selection method of htSNPs for determining a haplotype of human CYP1A2, CYP2A6, CYP2D6, PXR and UGT1A genes, a method of determining a genotype of the genes by using the htSNPs and a gene chip therefor.
    Type: Application
    Filed: June 26, 2007
    Publication date: June 24, 2010
    Applicant: INJE UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Jae-Gook Shin, Yin-jin Jang, Sang-seop Lee, Hye-eun Jeong, In-june Cha, Woo-young Kim, Sung-su Yea, Eun-young Kim, Eun-young Cha, Ji-hong Shon, Eun-jeong Choi, Kang-mi Kim, Hyun-ju Jung
  • ANTIBACTERIAL MACROLACTIN A THAT BACILLUS POLYFERMENTICUS KJS-2 PRODUCED IN
    Publication number: 20100087516
    Abstract: The present invention relates to uses of Macrolactin A produced by Bacillus polyfermenticus KJS-2 (KCCM 10769P), which is a new bacillus strain, as an antibiotic. Macrolactin A of the present invention, which is produced by Bacillus polyfermenticus KJS-2, shows a broad spectrum of antibiotic activity against a variety of microorganisms and fungi, and is proved to be very efficient for the inhibition of particularly vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus Aureus (MRSA) that are multidrug-resistant bacteria. The antibiotic Macrolactin A produced by Bacillus polyfermenticus KJS-2, can be used as an excellent antibiotic against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus Aureus (MRSA), and thus the present invention is a very useful invention for medical industry.
    Type: Application
    Filed: March 12, 2008
    Publication date: April 8, 2010
    Inventors: Jae-Seon Kang, Chun-Gyu Kim, Dong-Hee Kim, Kang-Min Kim, Dong-Hun Kim, Jin-Young Lee, Guang-Jin Choi, In-June Cha, Jae-Sun Hong, Yong-Geun Hong